This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): 15% Azelaic Acid (AzA)
Bayer also developed a separate formulation for Finacea (Gel).
Azelaic acid is an organic compound with the formula (CH2)7(CO2H)2. Azelaic acid is a naturally occurring molecule that can be found in barley and yeast as well as in the human body.
Intendis and Foamix
In January 2014, Intendis and Foamix announced that they have executed a worldwide license agreement for a dermatological foam. The agreement was signed following successful completion of Foamix's development of a novel alcohol-free foam.
Under the terms of the agreement, Intendis is to pay Foamix a signing fee and milestone payments, as well as royalties based on net sales. Intendis is a wholly owned subsidiary of Bayer.
Partners: Foamix Pharmaceuticals Ltd.
Finacea (Foam) News
Pink Sheet Berlex Finacea
Additional information available to subscribers only: